4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index
F Blanchon, M Grivaux, B Asselain, FX Lebas… - The lancet …, 2006 - thelancet.com
Background Lung cancer is the commonest cause of death due to cancer in the world. Non-small-cell
lung carcinoma (NSCLC) represents about 80% of overall lung cancer cases …
lung carcinoma (NSCLC) represents about 80% of overall lung cancer cases …
Major changes in lung cancer over the last ten years in France: the KBP-CPHG studies
…, B Asselain, F Martin, F Blanchon, M Grivaux - Lung Cancer, 2013 - Elsevier
The incidence of lung cancer has dramatically increased in ten years, being now the most
commonly diagnosed cancer in males and the fourth most commonly diagnosed cancer in …
commonly diagnosed cancer in males and the fourth most commonly diagnosed cancer in …
Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised …
…, JF Muir, S Dehette, J Virally, M Grivaux… - The Lancet …, 2022 - thelancet.com
Background Even after resection of early-stage non-small-cell lung cancer (NSCLC), patients
have a high risk of developing recurrence and second primary lung cancer. We aimed to …
have a high risk of developing recurrence and second primary lung cancer. We aimed to …
The new face of non-small-cell lung cancer in men: Results of two French prospective epidemiological studies conducted 10 years apart
…, V Tizon-Couetil, F Martin, M Grivaux - Lung cancer, 2016 - Elsevier
Objectives To evaluate the impact of epidemiological changes observed in 10 years in men
with NSCLC on 1-year mortality; to compare prognosis factors of 1-year mortality according …
with NSCLC on 1-year mortality; to compare prognosis factors of 1-year mortality according …
Prediagnosis weight loss, a stronger factor than BMI, to predict survival in patients with lung cancer
…, G Oliviero, C Marty, JP Gury, B Asselain, M Grivaux… - Lung Cancer, 2018 - Elsevier
Objectives Recent studies have demonstrated that elevated BMI is associated with improved
survival in patients with lung cancer. According to the authors, this “obesity paradox” could …
survival in patients with lung cancer. According to the authors, this “obesity paradox” could …
Five-year survival and prognostic factors according to histology in 6101 non-small-cell lung cancer patients
…, S Jeandeau, S Lacroix, F Martin, M Grivaux - … medicine and research, 2020 - Elsevier
Objective To estimate five-year survival in non-small-cell lung cancer (NSCLC) patients
according to histology and to identify independent prognostic factors by histology. Methods Data …
according to histology and to identify independent prognostic factors by histology. Methods Data …
[HTML][HTML] New insights into stage and prognosis in small cell lung cancer: an analysis of 968 cases
…, M Perrichon, F Martin, M Grivaux - Journal of thoracic …, 2017 - ncbi.nlm.nih.gov
Background The French College of General Hospital Respiratory Physicians conducted two
studies that consecutively included all patients followed in participating general hospitals for …
studies that consecutively included all patients followed in participating general hospitals for …
Epidemiologic of primary bronchial carcinoma management in the general French hospital centers
F Blanchon, M Grivaux, T Collon, M Zureik… - Revue des maladies …, 2002 - europepmc.org
Materials and methods A prospective epidemiological study was carried out on all the new
cases of histologically proven bronchial carcinoma seen in general hospitals in the year 2000…
cases of histologically proven bronchial carcinoma seen in general hospitals in the year 2000…
Five-year survival for lung cancer patients managed in general hospitals
M Grivaux, M Zureik, L Marsal, B Asselain… - Revue des maladies …, 2011 - Elsevier
INTRODUCTION: In 2000, the college of pulmonologists of general hospitals undertook an
epidemiological study (KBP-2000-CPHG) enrolling all new cases of histologically confirmed …
epidemiological study (KBP-2000-CPHG) enrolling all new cases of histologically confirmed …
[HTML][HTML] Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation: a randomised …
…, C Gimenez, F Barlesi, T Pignon, M Grivaux… - European Journal of …, 2016 - Elsevier
Purpose The objective of this randomised phase II study was to evaluate the impact in terms
of response and toxicities of induction or consolidation chemotherapy respectively before or …
of response and toxicities of induction or consolidation chemotherapy respectively before or …